Patients with these features who have anemia (hemoglobin (Hb) less than 11 g/dL) (formerly stage III) or thrombocytopenia (platelet count less than 100 × 109/L) (formerly stage IV) are considered high-risk disease patients [11,61]. This evidence concerns the gene GSTM1 and anemia.